Glucose transport in the heart

被引:162
作者
Abel, ED
机构
[1] Univ Utah, Sch Med, Div Endocrinol Diabet & Metab, Salt Lake City, UT 84112 USA
[2] Univ Utah, Program Human Mol Biol & Genet, Sch Med, Salt Lake City, UT 84112 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2004年 / 9卷
关键词
glucose transporters; GLUT1; GLUT4; heart; cardiomyocytes; review;
D O I
10.2741/1216
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The heart is a unique organ in many ways. It consists of specialized muscle cells (cardiomyocytes), which are adapted to contract constantly in a coordinated fashion. This is vital to the survival of the organism given the central role of the heart in the maintenance of the cardiovascular system that delivers oxygen, metabolic substrates and hormones to the rest of the body. In order for the heart to maintain its function it must receive a constant supply of metabolic substrates, to generate ATP to maintain contractile function, without fatigue. Thus the heart is capable of utilizing a variety of metabolic substrates and is able to rapidly adapt its substrate utilization in the face of changes in substrate supply. The major metabolic substrate for the heart is fatty acids. However, up to 30% of myocardial ATP is generated by glucose and lactate, with smaller contributions from ketones and amino acids. Although glucose is not the major metabolic substrate in the heart at rest, there are many circumstances in which it assumes greater importance such as during ischemia, increased workload and pressure overload hypertrophy. Like all other cells, glucose is transported into cardiac myocytes by members of the family of facilitative glucose transporters (GLUTs). In this regard, cardiomyocytes bear many similarities to skeletal muscle, but there are also important differences. For example, the most abundant glucose transporter in the heart is the GLUT4 transporter, in which translocation to the plasma membrane represents an important mechanism by which the net flux of glucose into the cell is regulated. Because cardiomyocytes are constantly contracting it is likely that contraction mediated GLUT4 translocation represents an important mechanism that governs the entry of glucose into the heart. While this is also true in skeletal muscle, because many muscles are often at rest, insulin mediated GLUT4 translocation represents a quantitatively more important mechanism regulating skeletal muscle glucose uptake than is the case in the heart. In contrast to skeletal muscle, where most GLUT1 is in perineural sheaths (1), in the heart there is significant expression of GLUT1 (2), which under certain circumstances is responsible for a significant component of basal cardiac glucose uptake. This review will summarize the current state of knowledge regarding the regulation of glucose transporter expression, and the regulation of glucose transport into myocardial cells.
引用
收藏
页码:201 / 215
页数:15
相关论文
共 151 条
  • [1] Abdel-aleem S, 1993, Diabetes Res, V22, P11
  • [2] REGULATION OF GLUCOSE-UTILIZATION DURING THE INHIBITION OF FATTY-ACID OXIDATION IN RAT MYOCYTES
    ABDELALEEM, S
    LI, X
    ANSTADT, MP
    PEREZTAMAYO, RA
    LOWE, JE
    [J]. HORMONE AND METABOLIC RESEARCH, 1994, 26 (02) : 88 - 91
  • [3] Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart
    Abel, ED
    Kaulbach, HC
    Tian, R
    Hopkins, JCA
    Duffy, J
    Doetschman, T
    Minnemann, T
    Boers, ME
    Hadro, E
    Oberste-Berghaus, C
    Quist, W
    Lowell, BB
    Ingwall, JS
    Kahn, BB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (12) : 1703 - 1714
  • [4] Glucose transporter protein responses to selective hyperglycemia or hyperinsulinemia in fetal sheep
    Anderson, MS
    Flowers-Ziegler, J
    Das, UG
    Hay, WW
    Devaskar, SU
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 281 (05) : R1545 - R1552
  • [5] Effect of recombinant human insulin-like growth factor-I on expression of glucose transporters, GLUT 2 and GLUT 4, in streptozotocin-diabetic rat
    Asada, T
    Ogawa, T
    Iwai, M
    Kobayashi, M
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 78 (01) : 63 - 67
  • [6] Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes
    Bahr, M
    Spelleken, M
    Bock, M
    vonHoltey, M
    Kiehn, R
    Eckel, J
    [J]. DIABETOLOGIA, 1996, 39 (07) : 766 - 774
  • [7] The stimulation of heart glycolysis by increased workload does not require AMP-activated protein kinase but a wortmannin-sensitive mechanism
    Beauloye, C
    Marsin, AS
    Bertrand, L
    Vanoverschelde, JL
    Rider, MH
    Hue, L
    [J]. FEBS LETTERS, 2002, 531 (02) : 324 - 328
  • [8] The endosomal compartment is an insulin-sensitive recruitment site for GLUT4 and GLUT1 glucose transporters in cardiac myocytes
    Becker, C
    Sevilla, L
    Tomàs, E
    Palacin, M
    Zorzano, A
    Fischer, Y
    [J]. ENDOCRINOLOGY, 2001, 142 (12) : 5267 - 5276
  • [9] Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice
    Belke, DD
    Larsen, TS
    Gibbs, EM
    Severson, DL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (05): : E1104 - E1113
  • [10] Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter
    Belke, DD
    Larsen, TS
    Gibbs, EM
    Severson, DL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (03): : E420 - E427